secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2026-08-05T20:10:26+00:00
Accession:  0001193125-26-335109
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q2 revenue $11.7M (+21% YoY); raises FY guidance to $45-47M
-----------------------------------------------------------------

- Revenue $11.7M, up 21% YoY; gross margin 72.1% vs 62.7% last year.
- Net loss $4.0M ($0.09/share) includes $1.2M non-cash derivative mark; operating loss improved to $2.3M from $4.6M.
- Adjusted EBITDA loss improved 79% to $0.8M from $4.0M.
- Record 255 orders in Q2 (+23% YoY); 53% of revenue from recurring patient sources (up from 26%).
- Raises FY 2026 revenue guidance to $45-47M; Q3 guidance $11.5-12.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/0001193125-26-335109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/myo-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-335109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer